Three new molecular diagnostic test panels for influenza and other common respiratory illnesses can be run together or alone using one patient sample
Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs
RSV is a common and pervasive cause of severe acute respiratory illness in older adults with no vaccine currently available
The company to receive upfront and milestone payments, in addition to royalties
Vapendavir is an oral, potent, broad-spectrum antiviral active against rhinoviruses and related respiratory enteroviruses
Esprit is a multicenter, randomized, placebo-controlled, double-blind study assessing the safety, pharmacodynamics, and preliminary efficacy of S-606001 as a substrate reduction therapy
India faces a significant and growing burden of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease
LTTS’ lung digital twin integrates seamlessly with CT imaging workflows, using deep learning to reconstruct a comprehensive 3D digital twin of the lungs
The approval means US laboratories can now run both respiratory and gastrointestinal panels on the high-throughput QIAstat-Dx Rise
Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk
Subscribe To Our Newsletter & Stay Updated
